Cargando…

Can new immunoassay techniques improve bladder cancer diagnostics With protein biomarkers?

The search for new diagnostic tests for cancer or ways to improve existing tests is primarily driven by the desire to identify the disease as early as possible. In this report, we summarize the current knowledge of the most promising diagnostic protein bladder cancer (BC) markers reported over the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Shlyapnikov, Yuri M., Malakhova, Ekaterina A., Vinarov, Andrey Z., Zamyatnin, Andrey A., Shlyapnikova, Elena A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917292/
https://www.ncbi.nlm.nih.gov/pubmed/33659273
http://dx.doi.org/10.3389/fmolb.2020.620687
_version_ 1783657667631251456
author Shlyapnikov, Yuri M.
Malakhova, Ekaterina A.
Vinarov, Andrey Z.
Zamyatnin, Andrey A.
Shlyapnikova, Elena A.
author_facet Shlyapnikov, Yuri M.
Malakhova, Ekaterina A.
Vinarov, Andrey Z.
Zamyatnin, Andrey A.
Shlyapnikova, Elena A.
author_sort Shlyapnikov, Yuri M.
collection PubMed
description The search for new diagnostic tests for cancer or ways to improve existing tests is primarily driven by the desire to identify the disease as early as possible. In this report, we summarize the current knowledge of the most promising diagnostic protein bladder cancer (BC) markers reported over the last decade. Unfortunately, analysis of published data suggests that a reliable, highly sensitive biomarker test-system based on ELISA for detecting BC has not yet been developed. The use of more sensitive assays to detect ultra-low concentrations of biomarkers not available for ELISA, could be very beneficial. Based on the literature and pilot experimental data, we conclude that a highly sensitive immunoassay using microarrays and magnetic labels, could be an effective and cheap technique suitable for the detection of diagnostically relevant BC biomarkers.
format Online
Article
Text
id pubmed-7917292
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79172922021-03-02 Can new immunoassay techniques improve bladder cancer diagnostics With protein biomarkers? Shlyapnikov, Yuri M. Malakhova, Ekaterina A. Vinarov, Andrey Z. Zamyatnin, Andrey A. Shlyapnikova, Elena A. Front Mol Biosci Molecular Biosciences The search for new diagnostic tests for cancer or ways to improve existing tests is primarily driven by the desire to identify the disease as early as possible. In this report, we summarize the current knowledge of the most promising diagnostic protein bladder cancer (BC) markers reported over the last decade. Unfortunately, analysis of published data suggests that a reliable, highly sensitive biomarker test-system based on ELISA for detecting BC has not yet been developed. The use of more sensitive assays to detect ultra-low concentrations of biomarkers not available for ELISA, could be very beneficial. Based on the literature and pilot experimental data, we conclude that a highly sensitive immunoassay using microarrays and magnetic labels, could be an effective and cheap technique suitable for the detection of diagnostically relevant BC biomarkers. Frontiers Media S.A. 2021-02-15 /pmc/articles/PMC7917292/ /pubmed/33659273 http://dx.doi.org/10.3389/fmolb.2020.620687 Text en Copyright © 2021 Shlyapnikov, Malakhova, Vinarov, Zamyatnin and Shlyapnikova. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Shlyapnikov, Yuri M.
Malakhova, Ekaterina A.
Vinarov, Andrey Z.
Zamyatnin, Andrey A.
Shlyapnikova, Elena A.
Can new immunoassay techniques improve bladder cancer diagnostics With protein biomarkers?
title Can new immunoassay techniques improve bladder cancer diagnostics With protein biomarkers?
title_full Can new immunoassay techniques improve bladder cancer diagnostics With protein biomarkers?
title_fullStr Can new immunoassay techniques improve bladder cancer diagnostics With protein biomarkers?
title_full_unstemmed Can new immunoassay techniques improve bladder cancer diagnostics With protein biomarkers?
title_short Can new immunoassay techniques improve bladder cancer diagnostics With protein biomarkers?
title_sort can new immunoassay techniques improve bladder cancer diagnostics with protein biomarkers?
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917292/
https://www.ncbi.nlm.nih.gov/pubmed/33659273
http://dx.doi.org/10.3389/fmolb.2020.620687
work_keys_str_mv AT shlyapnikovyurim cannewimmunoassaytechniquesimprovebladdercancerdiagnosticswithproteinbiomarkers
AT malakhovaekaterinaa cannewimmunoassaytechniquesimprovebladdercancerdiagnosticswithproteinbiomarkers
AT vinarovandreyz cannewimmunoassaytechniquesimprovebladdercancerdiagnosticswithproteinbiomarkers
AT zamyatninandreya cannewimmunoassaytechniquesimprovebladdercancerdiagnosticswithproteinbiomarkers
AT shlyapnikovaelenaa cannewimmunoassaytechniquesimprovebladdercancerdiagnosticswithproteinbiomarkers